| |
|
|
|
KemPharm Inc.  
|
|
2.01 -0.05 (-0.02%) |
03-21 11:35 |
|
Open: |
2.05 |
Pre close: |
2.06 |
Target:
|
2.69
|
|
High: |
2.0851 |
Low: |
1.99 |
Resistance:
|
2.30
2.57
|
|
Volume: |
67,274 |
Market Cap: |
54M |
Support:
|
1.87
1.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.04
 |
MACD |
MACD(12,26):
|
-0.09  |
|
MA(20): |
2.11 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
2.37 |
Stochastic Oscillator |
%K(14,3):
|
32.31 |
|
MA(250): |
4.10 |
%D(3): |
28.70 |
|
Average Volume(K) |
3-Month: |
12628
|
52-Week |
High:
|
8.00 |
|
10-Days: |
20420 |
Low: |
1.72 |
|
RSI |
RSI(14):
|
42.28 |
Change(%): |
-73.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.160 |
Return on Equity (ttm) |
91.0 |
Shares Out. (M) |
26.46 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-142.6 |
Shares Float (M) |
26.17 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.80 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
37.20 |
|
Forward EPS |
-2.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
162.740 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.64 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.20 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-27.85 |
P/CF |
-0.98 |
|
|
|
|
|
|
